IPP Bureau
Affordable Sitagliptin combinations for diabetics to be sold at Janaushadhi Kendras
By IPP Bureau - September 19, 2022
Sitagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Mandaviya inaugurates blood donation as part of Raktdaan Amrit Mahotsav
By IPP Bureau - September 19, 2022
Despite the technological advancements, there remains no alternative to blood and one unit of blood can save as many as three lives
Zydus receives tentative approval from USFDA for Sugammadex Injection
By IPP Bureau - September 19, 2022
Sugammadex is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults undergoing surgery
ENTOD Pharmaceuticals organises eye donation awareness campaign
By IPP Bureau - September 19, 2022
The #pledgemyeyes initiative reached out to over 30 million people across the country and the website registered 3X more pledges compared to the present numbers
Valent BioSciences promotes Salman Mir to EVP & COO
By IPP Bureau - September 19, 2022
We must bring logistics cost from 13% to single digit as soon as possible: Narendra Modi
By IPP Bureau - September 19, 2022
The policy aspires to reduce cost of logistics in India to be comparable to global benchmarks by 2030
Parexel appoints Peyton Howell and Amy McKee
By IPP Bureau - September 16, 2022
These moves are designed to strengthen the company’s medical and scientific focus and support its continued record growth through closer alignment of all aspects of strategy, sales, and delivery to delight customers
Philips highlights FetView cloud-based image sharing and reporting software for obstetrics and gynecology
By IPP Bureau - September 16, 2022
Philips FetView will offer real-time, off cart remote patient management with access to data from any ultrasound system
Pharmexcil to organise exhibition on pharma and healthcare on Sept 21-23
By IPP Bureau - September 16, 2022
The event is supported by the Ministry of Commerce & Industry, Government of India and CDSCO, Ministry of Health.
.jpg "Everstone acquires controlling stake in Softgel Healthcare"){kind=logo}
Everstone acquires controlling stake in Softgel Healthcare
By IPP Bureau - September 16, 2022
Veda Corporate Advisors was the exclusive financial advisor to SHPL and its shareholders.
Ascletis Pharma completes patient enrollment in clinical for cure of HIV infection
By IPP Bureau - September 16, 2022
The objective of this study is to evaluate the efficacy of ASC22 (Envafolimab) combined with Chidamide on the viral reservoirs of latently infected cells in HIV patients.
Cytel unlocks innovative clinical development expertise for APAC biopharma sector
By IPP Bureau - September 15, 2022
Cytel has now established entities in Australia, Shanghai, Beijing, and Singapore, and plans to expand into Seoul and Tokyo in the coming years.
Zydus receives final approval from USFDA for Lenalidomide Capsules
By IPP Bureau - September 15, 2022
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ, India
NMDP focuses on smooth transition to licensing of Class-A and B medical devices
By IPP Bureau - September 15, 2022
The Department of Health and Family Welfare updated the preparedness for transition to licensing of Class-A and Class-B medical devices with effect from 1st October, 2022 under Medical Devices Rules 2017
